Vanessa Soto-Cerrato

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Venues

Pharmaceutics

Cancers

Biomedicines

Medicinal research reviews

University of Barcelona

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Barcelona Sep 15 2018

Spain

Associate Professor :: Pathology and Experimental Therapeutics

Publications

Piedad Herrera-Ramírez, Sarah Alina Berger, Dana Josa, David Aguilà, Ana B Caballero, Pere Fontova, Vanessa Soto-Cerrato, Manuel Martínez, Patrick Gamez
Steric hindrance, ligand ejection and associated photocytotoxic properties of ruthenium(II) polypyridyl complexes. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry (2023)
Dana Josa, David Aguilà, Pere Fontova, Vanessa Soto-Cerrato, Piedad Herrera-Ramírez, Laia Rafols, Arnald Grabulosa, Patrick Gamez
Cytotoxicity of osmium(II) and cycloosmated half-sandwich complexes from 1-pyrenyl-containing phosphane ligands. Dalton transactions (Cambridge, England : 2003) (2023)
Adrià Molero-Valenzuela, Pere Fontova, Daniel Alonso-Carrillo, Israel Carreira-Barral, Ana Aurora Torres, María García-Valverde, Cristina Benítez-García, Ricardo Pérez Tomás, Roberto Quesada, Vanessa Soto-Cerrato
A Novel Late-Stage Autophagy Inhibitor That Efficiently Targets Lysosomes Inducing Potent Cytotoxic and Sensitizing Effects in Lung Cancer. Cancers 14 (14) (2022)
Margarita Espona-Fiedler, Pilar Manuel-Manresa, Cristina Benítez-García, Pere Fontova, Roberto Quesada, Vanessa Soto-Cerrato, Ricardo Pérez Tomás
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma. Pharmaceutics 15 (1) (2022)
Margarita Espona-Fiedler, Pilar Manuel-Manresa, Cristina Benítez-García, Pere Fontova, Roberto Quesada, Vanessa Soto-Cerrato, Ricardo Pérez Tomás
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma. Pharmaceutics 15 (1) (2022)
Margarita Espona-Fiedler, Pilar Manuel-Manresa, Cristina Benítez-García, Pere Fontova, Roberto Quesada, Vanessa Soto-Cerrato, Ricardo Pérez Tomás
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma. Pharmaceutics 15 (1) (2022)
Margarita Espona-Fiedler, Pilar Manuel-Manresa, Cristina Benítez-García, Pere Fontova, Roberto Quesada, Vanessa Soto-Cerrato, Ricardo Pérez Tomás
Antimetastatic Properties of Prodigiosin and the BH3-Mimetic Obatoclax (GX15-070) in Melanoma. Pharmaceutics 15 (1) (2022)
Marta Pérez-Hernández, Cristina Cuscó, Cristina Benítez-García, Joaquin Bonelli, Marina Nuevo-Fonoll, Aroa Soriano Fernandez, David Martínez-García, Alain Arias-Betancur, María García-Valverde, Miguel F Segura, Roberto Quesada, Josep Rocas, Vanessa Soto-Cerrato, Ricardo Pérez Tomás
Multi-Smart and Scalable Bioligands-Free Nanomedical Platform for Intratumorally Targeted Tambjamine Delivery, a Difficult to Administrate Highly Cytotoxic Drug. Biomedicines 9 (5) (2021)
Israel Carreira-Barral, Marcin Mielczarek, Daniel Alonso-Carrillo, Valeria Capurro, Vanessa Soto-Cerrato, Ricardo Pérez Tomás, Emanuela Caci, María García-Valverde, Roberto Quesada
Click-tambjamines as efficient and tunable bioactive anion transporters. Chemical communications (Cambridge, England) 56 (21) (2020)
Marta Pérez-Hernández, Alain Arias-Betancur, David Martínez-García, Ricardo Pérez Tomás, Roberto Quesada, Vanessa Soto-Cerrato
Targeting Autophagy for Cancer Treatment and Tumor Chemosensitization. Cancers 11 (10) (2019)
David Martínez-García, Marta Pérez-Hernández, Luís Korrodi-Gregório, Roberto Quesada, Ricard Ramos, Núria Baixeras, Ricardo Pérez-Tomás, Vanessa Soto-Cerrato
The Natural-Based Antitumor Compound T21 Decreases Survivin Levels through Potent STAT3 Inhibition in Lung Cancer Models. Biomolecules 9 (8) (2019)
David Martínez-García, Noemí Manero-Rupérez, Roberto Quesada, Luís Korrodi-Gregório, Vanessa Soto-Cerrato
Therapeutic strategies involving survivin inhibition in cancer. Medicinal research reviews 39 (3) (2018)

Vanessa Soto-Cerrato.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Vanessa Soto-Cerrato